Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2004
03/18/2004WO2003006641A3 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer
03/18/2004WO2003000274A3 Bacteriophage preparation for the treatment of intracellular bacterial infection
03/18/2004WO2002103024A3 Stabilized proteins with engineered disulfide bonds
03/18/2004WO2002090567A9 Sperm-specific cation channel, and uses therefor
03/18/2004US20040054410 Porosity biodegradation polymer shapes
03/18/2004US20040054313 Mixture with flow control agents; antiulcer agents
03/18/2004US20040054142 Cripto tumour polypeptide
03/18/2004US20040053875 Comprises double-stranded RNA; extracted from HeLa cells
03/18/2004US20040053869 Stem cell differentiation
03/18/2004US20040053366 Comprises nucleotide sequences coding leptin chimeric polypeptide for treatment and prevention of weight and cardiovascular disorders
03/18/2004US20040053262 Supressor gene
03/18/2004US20040052922 Nutritional and therapeutical preparations having antioxidant activity
03/18/2004US20040052879 Solvent extraction with methanol; isomerization; antitumor agents
03/18/2004US20040052871 Health enhancement system
03/18/2004US20040052860 Bone health compositions derived from milk
03/18/2004US20040052776 Method for inhibiting pathogenic fungi in plants using bacillus amyloliquefaciens
03/18/2004US20040052775 Antigens; induce immunology response; prevent infections; genetic engineering
03/18/2004US20040052773 Production of multi-chain protein from muscle
03/18/2004US20040052771 Hemangioblast progenitor cells
03/18/2004US20040052770 Interleukin-secreting natural killer cell lines and methods of use
03/18/2004US20040052769 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
03/18/2004US20040052768 Vascularised tissue graft
03/18/2004US20040052764 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
03/18/2004US20040050335 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
03/18/2004CA2538187A1 Pharmaceutical kits comprising mesenchymal stem cells
03/18/2004CA2498297A1 Recombinatant mutants of rhabdovirus and methods of use thereof
03/18/2004CA2497989A1 Probiotic bacterium: lactobacillus fermentum
03/18/2004CA2497895A1 Fibrin cell supports and methods of use thereof
03/18/2004CA2497750A1 Orthopoxvirus vectors, genes and products thereof
03/18/2004CA2497634A1 Compositions comprising bone marrow cells, demineralized bone matrix and various site-reactive polymers for use in the induction of bone and cartilage formation
03/18/2004CA2497552A1 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
03/18/2004CA2497193A1 Methods and compositions for tissue regeneration
03/18/2004CA2496888A1 Epitope sequences
03/17/2004EP1398377A1 Growth differentation Factor-7
03/17/2004EP1398369A1 Bifidobacteria and preparations containing them
03/17/2004EP1398038A1 Botulinum toxin pharmaceutical compositions
03/17/2004EP1397492A2 Modified and stabilized gdf propeptides and uses thereof
03/17/2004EP1397167A2 Wound closure system and methods
03/17/2004EP1397156A2 Oral administration of parathyroid hormone and calcitonin
03/17/2004EP1397154A2 Abin-mediated hepatitis protection
03/17/2004EP1397044A1 Prebiotic and probiotic compositions and methods for their use in gut-based therapies
03/17/2004EP1259112A4 Nutritional intervention composition for enhancing and extending satiety
03/17/2004EP1248834A4 Human embryoid body-derived cells
03/17/2004EP1242105B1 Combination of ginseng and ginkgo to improve cognitive skills
03/17/2004EP1214397B1 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway
03/17/2004EP0866655B1 Murine model for human carcinoma
03/17/2004EP0762881B1 Use of active agents for the manufacture of medicaments for the treatment of rheumatoid arthritis
03/17/2004CN1483074A System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells
03/17/2004CN1483040A Heart ankyrin repeat protein gene upstream sequence, carrier containing the same sequence and usage thereof
03/17/2004CN1482868A Nutritional composition with health promoting action containing oligosaccharides
03/17/2004CN1482861A Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk by filtration to remove bacteria
03/17/2004CN1482247A Non-antibiotics resistant shuttle plasmid expression carrier and its constructing method and uses
03/17/2004CN1481901A Hla matching donor-originating activated lymphocytes
03/17/2004CN1481892A Reptile phrynosoma tablet for curing pulmonary disease
03/17/2004CN1481884A Skin-infiltrating film of Chinese traditional medicine for curing paralysis resulting from central nerve trauma and its preparation method
03/17/2004CN1481872A Medication for psoriasis and its preparation method
03/17/2004CN1481863A Chinese traditional medicine for deafness and tinnitus and its preparation method
03/17/2004CN1481834A Bear gall pill of benefiting the liver
03/17/2004CN1481822A Bee glue tablet for diabetes and preparation process
03/17/2004CN1481821A Oral liquid of s snake extract
03/17/2004CN1481820A Intestine-resolved capsule of snake toxin extract for bloodvessel-related senility dementia
03/17/2004CN1481819A Hydrolyzation process of pearl powder suitable for ophthalmic medication
03/17/2004CN1481818A A scar-removing acne-controlling formulation and preparation method
03/17/2004CN1481817A Powder for trauma
03/17/2004CN1481816A Method of extracting Water-soluble antler extract product
03/17/2004CN1481815A Supercritical CO2 method of preparing antler extract product
03/17/2004CN1481814A Method of extracting alcohol-soluble freeze-dry antler extract product
03/17/2004CN1481813A Injection fluid of f reeze-dry powder for allaying fever
03/17/2004CN1142177C Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
03/17/2004CN1141978C Method for infecting mouse with pylorospirobacillus
03/17/2004CN1141973C Capsule for curing diabetes and its preparation method
03/17/2004CN1141969C Medicine for treating dermatopathy
03/17/2004CN1141967C Externally applied traditional Chinese medicine oil for treating burns and scalds
03/17/2004CN1141966C Medication for curing calculus of liver,gall and urinary tract
03/17/2004CN1141963C Ointment for curing hemorrhoids
03/17/2004CN1141962C Medicine for treating psoriasis
03/17/2004CN1141961C External-use traditional Chinese medicine for treating dermatosis
03/17/2004CN1141960C Traditional Chinese medicine composition applied via rectum and vagina for endometriosis and dysmenorrhea
03/17/2004CN1141958C Pile treating medication
03/17/2004CN1141955C Rheumatism treating tincture of external use
03/17/2004CN1141952C Medicine for curing shaoyang disease and its preparing method
03/17/2004CN1141946C Wind and cold dispelling traditional chinese medicine for treating facial palsy and its preparation method
03/17/2004CN1141945C Traditional chinese medicine formulation treating rheumarthritis and its preparation method
03/17/2004CN1141944C Preparation method of leukemia treating medicine extracted from viscera of scallop
03/17/2004CN1141943C Production process and product of instant osteocalcium powder composition
03/17/2004CN1141942C Health-care polypeptide product of nerve and its preparing process
03/17/2004CN1141933C Cold spring volcanic mud and pure bioactive factor composition and processing method thereof
03/16/2004US6706682 Increasing or maintaining the blood supply in the penis
03/16/2004US6706287 Microencapsulated or enteric coated composition comprising a probiotic, a prebiotic, and an ammoniaphilic urea degrading microorganism with high alkaline ph stability and high urease activity
03/16/2004US6706267 Glucosamine and egg for reducing inflammation
03/16/2004US6706263 Composition for alleviating symptoms of uremia in patients
03/11/2004WO2004021010A2 Method of diagnosing colon and gastric cancers
03/11/2004WO2004020733A1 Apparatus and method for automatically defibering and extracting kraft pulp from old corrugated cardboard
03/11/2004WO2004020639A2 Production of multimeric fusion proteins using a c4bp scaffold
03/11/2004WO2004020635A1 Bacteriophages and remedies for bacterial infection
03/11/2004WO2004020622A1 Methods of quantifying methotrexate metabolites
03/11/2004WO2004020601A2 Neurogenesis from hepatic stem cells
03/11/2004WO2004020014A2 Method of controlling pharmacokinetics of immunomodulatory compounds
03/11/2004WO2004019994A1 Ark5
03/11/2004WO2004019981A1 Method of diffrentiation and maturation of non-nerve cells into nerve cells, agent therefor and method of searching for the agent